Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
PLoS One. 2021 Oct 21;16(10):e0258482. doi: 10.1371/journal.pone.0258482. eCollection 2021.
Experimental studies have shown that vaccination can reduce viral replication to attenuate progression of influenza-associated lower respiratory tract illness (LRTI). However, clinical studies are conflicting, possibly due to use of non-specific outcomes reflecting a mix of large and small airway LRTI lacking specificity for acute lung or organ injury.
We developed a global ordinal scale to differentiate large and small airway LRTI in hospitalized adults with influenza using physiologic features and interventions (PFIs): vital signs, laboratory and radiographic findings, and clinical interventions. We reviewed the literature to identify common PFIs across 9 existing scales of pneumonia and sepsis severity. To characterize patients using this scale, we applied the scale to an antiviral clinical trial dataset where these PFIs were measured through routine clinical care in adults hospitalized with influenza-associated LRTI during the 2010-2013 seasons.
We evaluated 12 clinical parameters among 1020 adults; 210 (21%) had laboratory-confirmed influenza, with a median severity score of 4.5 (interquartile range, 2-8). Among influenza cases, median age was 63 years, 20% were hospitalized in the prior 90 days, 50% had chronic obstructive pulmonary disease, and 22% had congestive heart failure. Primary influencers of higher score included pulmonary infiltrates on imaging (48.1%), heart rate ≥110 beats/minute (41.4%), oxygen saturation <93% (47.6%) and respiratory rate >24 breaths/minute (21.0%). Key PFIs distinguishing patients with severity < or ≥8 (upper quartile) included infiltrates (27.1% vs 90.0%), temperature ≥ 39.1°C or <36.0°C (7.1% vs 27.1%), respiratory rate >24 breaths/minute (7.9% vs 47.1%), heart rate ≥110 beats/minute (29.3% vs 65.7%), oxygen saturation <90% (14.3% vs 31.4%), white blood cell count >15,000 (5.0% vs 27.2%), and need for invasive or non-invasive mechanical ventilation (2.1% vs 15.7%).
We developed a scale in adults hospitalized with influenza-associated LRTI demonstrating a broad distribution of physiologic severity which may be useful for future studies evaluating the disease attenuating effects of influenza vaccination or other therapeutics.
实验研究表明,接种疫苗可减少病毒复制,从而减轻流感相关下呼吸道疾病(LRTI)的进展。然而,临床研究结果存在争议,这可能是由于使用了反映大、小气道 LRTI 的非特异性结局,缺乏对急性肺或器官损伤的特异性。
我们开发了一种全球等级量表,用于通过生理特征和干预措施(PFIs)区分住院成人中流感引起的大、小气道 LRTI:生命体征、实验室和影像学发现以及临床干预。我们回顾了文献,以确定 9 种现有的肺炎和脓毒症严重程度量表中常见的 PFIs。为了使用该量表对患者进行特征描述,我们将该量表应用于抗病毒临床试验数据集,在该数据集中,通过 2010-2013 年季节中患有流感相关 LRTI 的住院成人的常规临床护理测量了这些 PFIs。
我们评估了 1020 名成年人中的 12 个临床参数;210 名(21%)经实验室确诊患有流感,中位数严重程度评分为 4.5(四分位距,2-8)。在流感病例中,中位年龄为 63 岁,20%在过去 90 天内住院,50%患有慢性阻塞性肺疾病,22%患有充血性心力衰竭。较高评分的主要影响因素包括影像学上的肺部浸润(48.1%)、心率≥110 次/分钟(41.4%)、血氧饱和度<93%(47.6%)和呼吸频率>24 次/分钟(21.0%)。区分严重程度<或≥8(上四分位数)的患者的关键 PFIs 包括浸润(27.1%比 90.0%)、体温≥39.1°C 或<36.0°C(7.1%比 27.1%)、呼吸频率>24 次/分钟(7.9%比 47.1%)、心率≥110 次/分钟(29.3%比 65.7%)、血氧饱和度<90%(14.3%比 31.4%)、白细胞计数>15,000(5.0%比 27.2%)和需要有创或无创机械通气(2.1%比 15.7%)。
我们在患有流感相关 LRTI 的住院成人中开发了一种量表,该量表显示出广泛的生理严重程度分布,这可能对未来评估流感疫苗或其他疗法对疾病缓解作用的研究有用。